More specifically, has been supposed that the inflammatory mediators that are present and released during the active phase of periodontal disease such as CRP, interleukins, prostaglandins, and metalloproteases, can negatively influence the release of Nitric Oxide (NO)19. The gene discussed is CRP; the disease is periodontal disorder.